Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?

被引：0
|
作者：
Congly, Stephen E. [1 ]
机构：
[1] Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Dept Med,Div Gastroenterol & Hepatol & Transplant, 6th Floor,Teaching Res & Wellness Bldg, Calgary, AB T2N 4N1, Canada
来源：
ANNALS OF HEPATOLOGY | 2022年 / 27卷 / 03期
关键词：
LONG-TERM MANAGEMENT; DE-NOVO MALIGNANCY;
D O I：
10.1016/j.aohep.2022.100703
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Post-transplant malignancy: reducing the risk in kidney transplant recipients
    Wu, Christine
    Shapiro, Ron
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1719 - 1729
  • [2] Development of Post-transplant Malignancy in Kidney Transplant Recipients
    Darema, Maria
    Vallianou, Kalliopi
    Kalogeropoulos, Petros
    Mantios, Evangelos
    Melexopoulou, Christina
    Paraskeva, Panoraia
    Bokos, Ioannis
    Marinaki, Smaragdi
    Boletis, Ioannis
    [J]. TRANSPLANTATION, 2022, 106 (09) : S630 - S630
  • [3] Post-transplant diabetes mellitus in Canadian liver and renal transplant recipients
    Dascal, Roman
    Wiebe, Chris
    Niazi, Mina
    Worobetz, Lawrence
    Bhanji, Rahima A.
    Knowles, Cori
    Uhanova, Julia
    Peretz, David
    Faisal, Nabiha
    Minuk, Gerald Y.
    [J]. CANADIAN LIVER JOURNAL, 2022, 5 (04): : 466 - 475
  • [4] Hypomagnesaemia, an independent risk factor for the development of post-transplant diabetes mellitus in liver and renal transplant recipients? A systematic review
    Chen, Shujie
    Bowen, David Geoffrey
    Liu, Ken
    Vidot, Helen
    [J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2024,
  • [5] Hypomagnesemia and risk of post-transplant lymphoproliferative disorder in liver transplant recipients
    Mahale, Parag
    Mckenna, Gregory J.
    Saracino, Giovanna
    Jennings, Linda
    Mbulaiteye, Sam M.
    Klintmalm, Goran B.
    Engels, Eric A.
    [J]. TRANSPLANT INTERNATIONAL, 2020, 33 (12) : 1835 - 1836
  • [6] Risk of post-transplant malignancy in pediatric kidney transplant recipients is not influenced by induction immunosuppression
    Charnaya, Olga
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26
  • [7] Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients
    Bustami, RT
    Ojo, AO
    Wolfe, RA
    Merion, RM
    Bennett, WM
    McDiarmid, SV
    Leichtman, AB
    Held, PJ
    Port, FK
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) : 87 - 93
  • [8] POST-TRANSPLANT DIABETES MELLITUS AS RISK FACTOR
    Idrizi, Alma
    Barbullushi, Myftar
    Thereska, Nestor
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 268 - 268
  • [9] Immunosuppression a risk factor for post-transplant diabetes
    [J]. Reactions Weekly, 2002, 894 (1) : 3 - 3
  • [10] PRE-TRANSPLANT MALIGNANCY ON KIDNEY TRANSPLANT RECIPIENTS IS NOT ASSOCIATED TO THE INCIDENCE OF POST-TRANSPLANT MALIGNANCY
    Ban, Tae Hyun
    Min, Ji Won
    Chung, Byung Ha
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 177 - 178
12345